Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 2026 AL 2040

Role of Neuroimaging Modality in the Assessment of Oxidative Stress in Brain: A Comprehensive Review

Pareek V, Nath B, Roy PK.

CNS Neurol Disord Drug Targets. 2019;18(5):372-381. doi: 10.2174/1871527318666190507102340.

Approach to Assessment of Parkinson Disease with Emphasis on Genetic Testing

Payne K, Walls B, Wojcieszek J.

Med Clin North Am. 2019 Nov;103(6):1055-1075. doi: 10.1016/j.mcna.2019.08.003. Epub 2019 Aug 31.

"Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression

Weiss HD, Pontone GM.

Neurol Clin Pract. 2019 Aug;9(4):354-359. doi: 10.1212/CPJ.0000000000000644.

Microglia in Parkinson's Disease

Ho MS.

Adv Exp Med Biol. 2019;1175:335-353. doi: 10.1007/978-981-13-9913-8_13.

Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease

Sacheli MA, Neva JL, Lakhani B, Murray DK, Vafai N, Shahinfard E, English C, McCormick S, Dinelle K, Neilson N, McKenzie J, Schulzer M, McKenzie DC, Appel-Cresswell S, McKeown MJ, Boyd LA, Sossi V, Stoessl AJ.

Mov Disord. 2019 Dec;34(12):1891-1900. doi: 10.1002/mds.27865. Epub 2019 Oct 4.

Association between Parkinson's Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis

Zhang P, Liu B.

ACS Chem Neurosci. 2019 Oct 16;10(10):4430-4439. doi: 10.1021/acschemneuro.9b00498. Epub 2019 Oct 4.

Neural bases of impulse control disorders in Parkinson's disease: A systematic review and an ALE meta-analysis

Santangelo G, Raimo S, Cropano M, Vitale C, Barone P, Trojano L.

Neurosci Biobehav Rev. 2019 Dec;107:672-685. doi: 10.1016/j.neubiorev.2019.09.041. Epub 2019 Oct 3.

The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease

Jęśko H, Lenkiewicz AM, Wilkaniec A, Adamczyk A.

Acta Neurobiol Exp (Wars). 2019;79(3):276-289.

Dopamine and the motivation of cognitive control

Cools R, Froböse M, Aarts E, Hofmans L.

Handb Clin Neurol. 2019;163:123-143. doi: 10.1016/B978-0-12-804281-6.00007-0.

Gastrointestinal Immunity and Alpha-Synuclein

Barbut D, Stolzenberg E, Zasloff M.

J Parkinsons Dis. 2019;9(s2):S313-S322. doi: 10.3233/JPD-191702.

Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study

Carroll CB, Webb D, Stevens KN, Vickery J, Eyre V, Ball S, Wyse R, Webber M, Foggo A, Zajicek J, Whone A, Creanor S.

BMJ Open. 2019 Oct 7;9(10):e029740. doi: 10.1136/bmjopen-2019-029740.

International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci

Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen CY, Choi KW, Coleman JRI, Dalvie S, Duncan LE, Gelernter J, Levey DF, Logue MW, Polimanti R, Provost AC, Ratanatharathorn A, Stein MB, Torres K, Aiello AE, Almli LM, Amstadter AB, Andersen SB, Andreassen OA, Arbisi PA, Ashley-Koch AE, Austin SB, Avdibegovic E, Babić D, Bækvad-Hansen M, Baker DG, Beckham JC, Bierut LJ, Bisson JI, Boks MP, Bolger EA, Børglum AD, Bradley B, Brashear M, Breen G, Bryant RA, Bustamante AC, Bybjerg-Grauholm J, Calabrese JR, Caldas-de-Almeida JM, Dale AM, Daly MJ, Daskalakis NP, Deckert J, Delahanty DL, Dennis MF, Disner SG, Domschke K, Dzubur-Kulenovic A, Erbes CR, Evans A, Farrer LA, Feeny NC, Flory JD, Forbes D, Franz CE, Galea S, Garrett ME, Gelaye B, Geuze E, Gillespie C, Uka AG, Gordon SD, Guffanti G, Hammamieh R, Harnal S, Hauser MA, Heath AC, Hemmings SMJ, Hougaard DM, Jakovljevic M, Jett M, Johnson EO, Jones I, Jovanovic T, Qin XJ, Junglen AG, Karstoft KI, Kaufman ML, Kessler RC, Khan A, Kimbrel NA, King AP, Koen N, Kranzler HR, Kremen WS, Lawford BR, Lebois LAM, Lewis CE, Linnstaedt SD, Lori A, Lugonja B, Luykx JJ, Lyons MJ, Maples-Keller J, Marmar C, Martin AR, et al.

Nat Commun. 2019 Oct 8;10(1):4558. doi: 10.1038/s41467-019-12576-w.

Subtyping of Parkinson's Disease - Where Are We Up To?

Qian E, Huang Y.

Aging Dis. 2019 Oct 1;10(5):1130-1139. doi: 10.14336/AD.2019.0112. eCollection 2019 Oct.

"Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome?

Liebert A, Bicknell B, Johnstone DM, Gordon LC, Kiat H, Hamblin MR.

Photobiomodul Photomed Laser Surg. 2019 Nov;37(11):681-693. doi: 10.1089/photob.2019.4628. Epub 2019 Oct 9.

Effectiveness of occupational therapy intervention for people with Parkinson's disease: Systematic review

Welsby E, Berrigan S, Laver K.

Aust Occup Ther J. 2019 Dec;66(6):731-738. doi: 10.1111/1440-1630.12615. Epub 2019 Oct 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias